News | Optical Coherence Tomography (OCT) | June 26, 2020

OCT Imaging Changed Treatment Decisions in 88 Percent of Artery Blockages in New Study

Using optical coherence tomography-guided PCI physicians were able to select the right size stents and place them with greater precision

Abbott OCT intravascular imaging explained.

June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence tomography (OCT) imaging significantly changes how physicians decide to treat a vessel compared to traditional angiography by providing physicians improved visualization within a patient's blood vessels. Data from the study revealed physicians altered their treatment strategy in 88 percent of coronary artery blockages based on new information provided by OCT.

"After planning a procedure with angiography alone, we exposed physicians to all the information provided by OCT on the same blockage and were able to demonstrate the significant impact that the information had on our decisions," said Hiram Bezerra, M.D., professor of medicine at the University of South Tampa and the director of cardiac interventional services at Tampa General Hospital in Florida. "OCT takes the guesswork out of angiography, offering doctors real-time high-quality granularity and precision when performing PCIs, and helping doctors make real-time decisions in the cath lab."

This is the first data release from Abbott's LightLab Initiative, which was presented as part of a virtual three-day PCR e-Course held by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), June 25-27. The new data provides strong evidence of the value of using OCT for decision-making within the PCI procedure. Initial data found:
   • OCT changes angiographic-based decisions in 88% of lesions.
   • After deploying a stent, physicians made changes in treating 31% of lesions based on OCT information to treat damage to the artery previously invisible with angiography alone.
   • Physicians improved their assessment of potential blockages as a result of using OCT, which better helped inform which size of stent to use and optimal stent deployment compared with angiography alone.

"The LightLab Initiative has given us great insights into the challenges facing interventional cardiologists in the cath lab and the impact OCT can have on the decisions physicians make in treating their patients," said Nick West, M.D., divisional vice president, medical affairs, and chief medical officer of Abbott's vascular business. "The data has also highlighted how effective OCT can be at treating patients with complex cardiovascular disease with greater precision."

Abbott Vascular LightLab Initiative

The LightLab Initiative was designed to examine the role and impact of OCT on physician decision-making, procedural efficiency and procedural safety over angiography during procedures for patients with vascular disease.  Abbott field clinical engineers collaborated with interventional cardiologists in 12 medical centers across the United States and collected PCI procedural data over a 12-month period.

Of the 2,203 procedures and 1,016 interventions that were assessed in the first phase of the LightLab Initiative, doctors used OCT before and after stenting in 652 lesions.

The level of detail and the volume of data collected in this real-world patient cohort demonstrates a clear and important impact of OCT on lesion assessment, procedural planning and stent optimization, with further analyses from subsequent phases of the program planned in coming months. The subsequent phases of the LightLab Initiative will focus on optimizing the prescribed treatment steps when using OCT to achieve greater efficiency (shorter timing) and safety (lower contrast and radiation exposure) gains, thereby identifying and removing barriers to OCT adoption.

 

About Optical Coherence Tomography

Imaging techniques such as OCT have been shown to improve outcomes during stenting procedures,[1] but remain underutilized. OCT is an intracoronary imaging platform that uses light-based technology to help characterize and assess coronary arteries from inside the vessel with high precision, allowing for assessment of the degree and characteristics of coronary artery disease, accurate dimensional measurement of the artery and assessment of the quality of stent deployment.[2]

Using laser technology, OCT captures high-resolution images inside a patient's arteries, displaying the type and severity of disease in the vessel, as well as enabling more accurate measurements to determine how the patient should be treated.

Find more OCT content

For more information: www.abbott.com

References:

1. Jones, Daniel A. et al "Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention." JACC: Cardiovascular Interventions 11.14 (2018): 1313-1321. Web. 23 Aug. 2018.

2. https://www.cathlabdigest.com/content/next-innovation-pci-not-stent-value-optical-coherence-tomography-oct

Related Content

News | Cardiac Imaging

November 10, 2021 — Philips, a global leader in health technology, announced that it has signed an agreement to acquire ...

Home November 10, 2021
Home
News | Cardiac Imaging

November 1, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), radiologists need to be cognizant of the ...

Home November 01, 2021
Home
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Home October 06, 2021
Home
News | Cardiac Imaging

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...

Home September 22, 2021
Home
Feature | Cardiac Imaging | By Dave Fornell, Editor

In the past several years, a few cardiac ultrasound vendors have developed new ways to image the intricate flow of ...

Home August 17, 2021
Home
News | Cardiac Imaging

June 15, 2021 — A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of ...

Home June 15, 2021
Home
News | Cardiac Imaging

June 14, 2021 — Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly ...

Home June 14, 2021
Home
News | Cardiac Imaging

May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 ...

Home May 12, 2021
Home
News | Cardiac Imaging

March 31, 2021 — ScImage Inc. celebrates its cloud partnership with Digirad Health after a year of successful deployment ...

Home March 31, 2021
Home
Subscribe Now